225 related articles for article (PubMed ID: 10976622)
21. A statistical assessment of the biological relationship between simultaneous canine mammary tumours.
Gunnes G; Borge KS; Lingaas F
Vet Comp Oncol; 2017 Jun; 15(2):355-365. PubMed ID: 26452754
[TBL] [Abstract][Full Text] [Related]
22. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
23. Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors.
Lim HY; Im KS; Kim NH; Kim HW; Shin JI; Sur JH
Vet J; 2015 Mar; 203(3):326-31. PubMed ID: 25641553
[TBL] [Abstract][Full Text] [Related]
24. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
25. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
26. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
[TBL] [Abstract][Full Text] [Related]
27. Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours.
Song D; Oh YI; Kim JM; Cheon DS; Kim DY; Seo KW
Vet Med Sci; 2020 Nov; 6(4):958-964. PubMed ID: 32657032
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
30. Influence of host factors on survival in dogs with malignant mammary gland tumors.
Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
[TBL] [Abstract][Full Text] [Related]
31. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem.
Salas Y; Márquez A; Diaz D; Romero L
PLoS One; 2015; 10(5):e0127381. PubMed ID: 25992997
[TBL] [Abstract][Full Text] [Related]
33. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
34. Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer.
Vascellari M; Capello K; Carminato A; Zanardello C; Baioni E; Mutinelli F
Prev Vet Med; 2016 Apr; 126():183-9. PubMed ID: 26948297
[TBL] [Abstract][Full Text] [Related]
35. Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining.
Matos AJ; Faustino AM; Lopes C; Rutteman GR; Gärtner F
Vet Rec; 2006 May; 158(18):626-30. PubMed ID: 16679481
[TBL] [Abstract][Full Text] [Related]
36. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
[TBL] [Abstract][Full Text] [Related]
37. Expression and prognostic value of TRPM7 in canine mammary tumours.
Lee S; Lee S; Kim WH
Vet Comp Oncol; 2021 Sep; 19(3):510-517. PubMed ID: 33617107
[TBL] [Abstract][Full Text] [Related]
38. Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours.
Restucci B; Martano M; Maiolino P
Res Vet Sci; 2015 Jun; 100():182-8. PubMed ID: 25816929
[TBL] [Abstract][Full Text] [Related]
39. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002.
Egenvall A; Bonnett BN; Ohagen P; Olson P; Hedhammar A; von Euler H
Prev Vet Med; 2005 Jun; 69(1-2):109-27. PubMed ID: 15899300
[TBL] [Abstract][Full Text] [Related]
40. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.
Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
